Fulgent Genetics (MEX:FLGT) Ending Cash Position : MXN907 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Ending Cash Position?

Fulgent Genetics's Ending Cash Position for the quarter that ended in Mar. 2024 was MXN907 Mil.

Fulgent Genetics's quarterly Ending Cash Position increased from Sep. 2023 (MXN1,465 Mil) to Dec. 2023 (MXN1,655 Mil) but then declined from Dec. 2023 (MXN1,655 Mil) to Mar. 2024 (MXN907 Mil).

Fulgent Genetics's annual Ending Cash Position declined from Dec. 2021 (MXN3,383 Mil) to Dec. 2022 (MXN1,550 Mil) but then increased from Dec. 2022 (MXN1,550 Mil) to Dec. 2023 (MXN1,655 Mil).

Fulgent Genetics Ending Cash Position Historical Data

The historical data trend for Fulgent Genetics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Ending Cash Position Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

225.66

1,739.08

3,382.64

1,550.05

1,654.53

Fulgent Genetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,192.75	1,000.31	1,464.51	1,654.53	907.43

Fulgent Genetics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Fulgent Genetics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1349.554	+	304.977
	=	1,655

Fulgent Genetics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1617.687	+	-710.254
	=	907

Fulgent Genetics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics (MEX:FLGT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.